Thomas Braxton King, President & CEO at Alexza Pharmaceuticals Inc. (ALXA), sold 12,500 shares at $6.67 ($83K) on 2008-02-11, disclosed to the SEC on 2008-02-12.
Scheduled sale ($83k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.55 | 564 | $4K | 4.4% |
| 2 | $6.60 | 200 | $1K | 1.6% |
| 3 | $6.61 | 2,658 | $18K | 21.1% |
| 4 | $6.62 | 400 | $3K | 3.2% |
| 5 | $6.63 | 100 | $663 | 0.8% |
| 6 | $6.64 | 100 |
| $664 |
| 0.8% |
| 7 | $6.65 | 2,342 | $16K | 18.7% |
| 8 | $6.66 | 200 | $1K | 1.6% |
| 9 | $6.67 | 100 | $667 | 0.8% |
| 10 | $6.68 | 100 | $668 | 0.8% |
| 11 | $6.69 | 900 | $6K | 7.2% |
| 12 | $6.70 | 2,736 | $18K | 22.0% |
| 13 | $6.74 | 2,100 | $14K | 17.0% |
| Total | $6.66 avg | 12,500 | $83K | 100% |
| Filing → |
| ALXA | SELL | 2012-08-29 | $41K | — | Filing → |
| ALXA | SELL | 2012-06-08 | $22K | — | Filing → |
| ALXA | SELL | 2009-12-21 | $100K | — | Filing → |